HIV‐1 Tat inhibits NGF‐Induced Egr‐1 transcriptional activity and consequent p35 expression in neural cells
Authors:
- 4 February 2008
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 216 (1) , 128-134
Abstract
Infection with HIV‐1 causes degeneration of neurons leading to motor and cognitive dysfunction in AIDS patients. One of the key viral regulatory proteins, Tat, which is released by infected cells, can be taken up by various uninfected cells including neurons and by dysregulating several biological events induces cell injury and death. In earlier studies, we demonstrated that treatment of neuronal cells with Tat affects the nerve growth factor (NGF) signaling pathway involving MAPK/ERK. Here we demonstrate that a decrease in the level of Egr‐1, one of the targets for MAPK, by Tat has a negative impact on the level of p35 expression in NGF‐treated neural cells. Further, we demonstrate a reduced level of Egr‐1 association with the p35 promoter sequence in NGF‐treated cells expressing Tat. As p35, by associating with Cdk5, phosphorylates several neuronal proteins including neurofilaments and plays a role in neuronal differentiation and survival, we examined kinase activity of p35 complexes obtained from cells expressing Tat. Results from H1 kinase assays showed reduced activity of the p35 complex from Tat‐expressing cells in comparison to that from control cells. Accordingly, the level of phosphorylated neurofilaments was diminished in Tat‐expressing cells. Similarly, treatment of PC12 cells with Tat protein or supernatant from HIV‐1 infected cells decreased kinase activity of p35 in these cells. These observations ascribe a role for Tat in altering p35 expression and its activity that affects phosphorylation of proteins involved in neuronal cell survival. J. Cell. Physiol. 216: 128–134, 2008.Keywords
This publication has 61 references indexed in Scilit:
- Recruitment of active glycogen synthase kinase-3 into neuronal lipid raftsBiochemical and Biophysical Research Communications, 2006
- Dysregulation of NGF‐signaling and Egr‐1 expression by Tat in neuronal cell cultureJournal of Cellular Physiology, 2006
- Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr‐1Journal of Cellular Biochemistry, 2004
- Up-Regulation of Egr1 by 1,25-Dihydroxyvitamin D3 Contributes to Increased Expression of p35 Activator of Cyclin-Dependent Kinase 5 and Consequent Onset of the Terminal Phase of HL60 Cell DifferentiationCancer Research, 2004
- Constitutively active Src facilitates NGF‐induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK‐N‐MC cellsFEBS Letters, 2004
- ERK and p38 Inhibit the Expression of 4E-BP1 Repressor of Translation through Induction of Egr-1Journal of Biological Chemistry, 2003
- HIV-1 Tat Protein-mediated Transactivation of the HIV-1 Long Terminal Repeat Promoter Is Potentiated by a Novel Nuclear Tat-interacting Protein of110 kDa, Tip110Journal of Biological Chemistry, 2002
- Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanismsOncogene, 1999
- Molecular Cloning and Chromosomal Mapping of the Mouse Gene Encoding Cyclin-Dependent Kinase 5 Regulatory Subunit p35Genomics, 1996
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988